Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

MC-02331, a new cephalosporin with excellent activity against Gram-positive bacteria

Oct. 11, 1996

Metallo-beta-lactamase inhibitors from SKB

Oct. 11, 1996

Penam sulfones with beta-lactamase-inhibitory activity

Oct. 11, 1996

Antiviral/corticosteroid therapy beneficial for herpes zoster

Oct. 4, 1996

Roche and Gilead Sciences collaborate on the development of neuraminidase inhibitors

Oct. 4, 1996

Development of ViroPharma's lead antiviral drug progresses

Oct. 4, 1996

Sch-48973, a potent, broad-spectrum antienterovirus compound

Oct. 4, 1996

Dana Farber discloses unique antiherpetic therapy

Oct. 4, 1996

AmBisome licensed to Sumitomo

Oct. 4, 1996

Antiherpesvirus agents from Eisai

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...